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ABSTRACT 
 
In this work, three pH values (8, 9 and 10) were studied for the insertion of Indomethacin (Indo) molecules into 
Layered Double Hydroxides (LDHs). The obtained results showed that the LDH materials have been a good 
storage for the drug.  LDHs provide thermal stability with an increase in the thermal decomposition of the drug 
around 100°C more. Indo into LDHs exhibited higher photostability to UV light irradiation. In vitro drug release 
experiments in a phosphate buffer solution (pH = 7.4) have been carried out. The loading amount of intercalated 
Indo was increased to 66 % at pH 8, and showed a profile of sustained release of 97 % in 8h. The release 
profiles were fitted by mathematical models, which describe various kinetic models that served to investigate 
the drug release mechanism, being the Bhaskar kinetics model the most appropriate. The results showed that the 
nanohybrids can be used as an effective drug delivery system. 
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INTRODUCTION 
 
Layered Double Hydroxides (LDH), also known as 
hydrotalcite like compounds or anionic clay, are a 
class of host-guest layered solids and they are 
usually represented by the general formula [M2+(1-x) 
M3+x (OH)2]x+ (An-x/n). mH2O, where M2+ and M3+ 
are the di-, trivalent metal cations, A is an organic 
or inorganic anion, m is the number of interlayer 
water and x is the layer charge density of LDH. 
Their structure consists of brucite-like layers, 
where the substitution of M2+ for M3+ cations, leads 
to an excess of positive charge, which is balanced 
by anions located together with water molecules in 
the interlayer [1]. Through direct synthesis it is 
possible to introduce any type of anion between its 
layers. These anions can be replaced by others, via 
ion-exchange, with subsequent variation of the 
interlayer distance that depends on the size of the 
intercalated anions.  
 
Nanobiohybrids are based on a layered inorganic 
host that can intercalate various biological 
materials in the nanometer size galleries between 
the layers. In particular, the combination of the 
synthesis of nanobiohybrids and the intercalation 
technique offers a new area for developing 
nanohybrids with a desired functionality. 
Consequently, the interlayer region of a laminate 
host may be considered a micro vessel in which an 
anionic drug may be stored and successively 
released as an effect of an intercalation process 2. 
The ability of LDH to exchange the interlayer 
anion has been clearly proven in the consulted 
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literature and, thus, they may be used as 
biocompatible hosts for several drugs [3, 4]. 
 
The applications of MgAl-LDH in Medicine and 
Pharmacy have been almost exclusively restricted 
to its role as antacid or anti-pepsinic. Recently, 
anionic, drug molecules have been intercalated into 
a variety of LDH 2, 5-11. Moreover, they may act 
as stable host matrices for storage and delivery of 
various intercalated bioactive molecules and drugs 
[12-16]. One important feature they exhibit is that 
the labile, bioactive substances intercalated into 
LDH could be effectively protected against rapid 
degradation by light, temperature, oxygen, alkali 
metals, etc., [17-19]. In their recent studies, Wei et 
al. [20] have demonstrated that the intercalation of 
the chiral drug L-dopa into MgAl LDH enhanced 
significantly its chemical stability. Kura et al. [21] 
found that the layered hydroxide nanocomposite 
containing the Levodopa anti-Parkinsonian agent is 
a possible alternative choice for a nano delivery 
system for chronic Parkinson’s disease treatment 
rather than conventional Levodopa.  
 
Choy et al. [22] first developed the DNA-LDHs 
nanohybrids for efficient gene delivery, and it was 
shown that the DNA molecules could be easily 
intercalated into LDHs by anion exchange. Lun 
Dong et al. [23] studied the incorporation of 
Camptothecin into LDH by reconstruction 
methods, profiles and kinetics release. On the other 
hand, a variety of pharmaceutical, anionic materials 
were intercalated into the LDH, some examples of 
non-steroidal, anti-inflamatory drugs (NSAIDs) 
are: Ibuprofen, Diclofenac, Naproxen, etc. [24, 25]. 
The release properties of the NSAIDs have been 
investigated by adding their intercalation 
compounds to samples of simulated gastrointestinal 
and intestinal fluids. Ambrogi et al. 2 have 
reported on the intercalation of Diclofenac, finding 
that the microencapsulation of drugs immobilized 
on Mg-Al-LDH was successively achieved in order 
to obtain a new, enteric, composite system for a 
potential, colonic drug delivery. Li et al. [26] have 
studied Fenbufen-intercalated LDH as the core was 
coated with enteric polymers, Eudragit® S 100 or 
Eudragit® L100 as a shell, resulting in a composite 
material which showed controlled release of the 
drug under in vitro conditions.  
 
Among the members of the NSAIDs, there is 
Indomethacin. It is used to reduce pain caused by 
osteoarthritis, rheumatoid arthritis, bursitis, gout, 
etc. [27], however, it has well known side effects 
including gastrointestinal disturbances. The drug is 
described as poorly soluble and highly permeable 
(class II). Given that water-insoluble drugs often 
show low absorption and weak bioavailability, 
improvements in dissolution rates and/or solubility 
are important for the development of drug 
preparations. The successful formulation of poorly 
water-soluble drugs is one of the major problems in 
pharmaceutical manufacturing. Indo exists in two 
stable polymorphic forms, termed γ-form and α-
form. The γ form, with the highest point of fusion 
and consequently, the least soluble is 
thermodynamically the most stable. El-Brady et al. 
[28] have reported on the study about solid-state 
properties of the solid, dispersion system of Indo in 
PEG400 (polyethylene glycol 4000) and Gelucire 
50/13. Gelucire is a family of vehicles derived from 
the mixtures of mono-, di- and triglycerides with 
polyethylene glycol esters of fatty acids. Del Río 
[29, 30] has studied the polymorphism 
phenomenon in the formulation of Indo tablets, and 
their behavior during the study of dissolution. Del 
Arco et al. [31] have studied LDH synthesized at a 
wide range of pH (8-9), by reconstruction methods 
of LDH and have focused on the gastric, membrane 
damage. On the other hand, Indo is sensitive to the 
exposure to strong, direct sunlight [32] and 
photolabile in organic solvents [33]. Under UV 
light, the primary degradation products are alcohol, 
aldehyde and decarboxylation [34]. Regarding 
solid stability during storage, it should be stored in 
closed containers protected from light, as it is 
photosensitive. 
 
Thus, the purpose of this work is to study the 
intercalation of Indo by direct synthesis into LDH 
using a coprecipitation method at different pH 
(between 8 and 10 ±0.2), and then to determine the 
recommended pH value to achieve a greater 
incorporation - release. The drug release from the 
obtained nanohybrids was analyzed in a simulated 
intestinal media (pH 7.4). The release profile data 
were fitted by mathematical models which describe 
various kinetic mechanisms. Furthermore, the 
photostability to UV light irradiation and thermal 
decomposition of the drug are studied to infer 
whether the host-guest structure (LDH-drug) 
provides some benefits.  
 
EXPERIMENTAL 
Synthesis of the samples: The LDH with 
intercalated Indomethacin (LDH-Indo) have been 
prepared by direct coprecipitation from Mg and Al 
chlorides, a similar method to the one described by 
Dupin et al. [35]. Two aqueous solutions of 
AlCl3.6H2O and MgCl2.6H2O were dissolved in 
100 mL of decarbonated water, with the 
relationship M2+/M3+ = 2. The aqueous solution 
was slowly added to 50 mL of decarbonated water 
with Indomethacin, and the suspension was stirred 
magnetically. The coprecipitation was carried out 
at 35 °C under nitrogen atmosphere, to avoid the 
incorporation of CO2. For the synthesis, three pH 
values were studied (8, 9 and 10) ± 0.2, the pH was 
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maintained constant by continuously adding NaOH 
0.1 M, which made also the drug gradually 
solubilize. The resulting suspension was stirred for 
20 h at 60 ºC under nitrogen atmosphere. The 
product was filtered, washed with decarbonated 
water at 60 ºC and finally dried at room 
temperature. The sample without drug was 
prepared to compare it with the incorporated host. 
This sample was called LDH-Cl. 
 
Characterization of the samples: Powder X-ray 
diffraction (XRD) data were collected on a X´Pert 
Pro-PANalytical diffractometer using Cu Kα 
radiation (λ = 1.54 Å) in a scan range between 1.5º 
and 70º at a scan speed of 3º/min in 2θ and step 
size 0.02º.  
 
FT-IR spectra were recorded on a Jasco FT/IR 
5300 spectrometer in air at room temperature. The 
sample was pressed into a disc with KBr. The 
spectrum of each sample was recorded by 
accumulating 48 scans at 2 and 4 cm-1, resolution 
between 400 and 4000 cm-1. 
 
The scanning electron microscopy (SEM) study of 
the parent LDH, were obtained in a JEOL JSM-
6380 LV. Gold Coverage was applied to make 
samples conductive. The acceleration voltage was 
20 kV. 
Moreover, the solids were analyzed by 
transmission electron microscopy (TEM) with a 
JOEL JEM-1200 EX II. A small drop of the 
dispersion (sample in solution water-ethanol 50%) 
was deposited on a copper grid and then evaporated 
in air at room temperature.  
 
Drug loading was determined by UV absorption 
spectrophotometer using a Jasco 7800 at λ=320 nm. 
The measurements of the calibration curve obtained 
from five solutions were analyzed in fivefold by 
UV absorption at λ=320 nm. These measurements 
were analyzed through a linear regression method, 
in which the correlation coefficient (R2= 0,999) and 
the equation of a straight line were calculated. A  
specific amount of LDH-Indo was dissolved in 10 
mL of  HCl 1M solution under magnetic stirring for 
2 h to dissolve the LDH matrix and then it was 
diluted with phosphate buffer at pH 7.4 [36]. 
Precision was examined by the standard deviation 
(S.D.) of recovery data (n=3).  
 
Thermogravimetric analyses (TG) and differential 
scanning calorimetry analyses (DSC) were 
performed by means of an automatic thermal 
analyzer (TA SDT Q600) Thermal analyses were 
conducted at a scanning rate of 10 °C/min from 20 
to 600 °C. The degradation study was carried out 
with a model PHILIPS TL 8W/05 lamp, which has 
a maximum energy emission of 365 nm, in the 
region of UV-A and UV-B. Exposure took place 
directly on the LDH-Indo into an enclosure, during 
certain periods, from 30 minutes to 16 hours; the 
changes in the solid were analyzed by UV-visible 
diffuse reflectance (UV-vis-DR) with a Jasco V-
650 spectrophotometer in the range of 200-900 nm. 
 
Drug release studies were performed in the 
dissolution apparatus Hanson Research SR6 serie II 
baskets type. The baskets rotation speed was 50 
rpm and the vessels were kept in a thermostatically 
controlled circulation water bath at 37.0±0.5 °C. 
The dissolution media were simulated, intestinal 
fluids at pH 7.4±0.05. The release studies were 
done by placing a given amount of LDH-Indo in 
750 mL of medium under sink conditions. The 
samples of 7 mL were withdrawn at predetermined 
intervals, followed by replenishment after each 
withdrawal with the same volume of fresh medium 
equilibrated at 37.0±0.5 °C. They were 
appropriately filtered (filter type: 0.45 μm, 
Milipore 13 mm) and analyzed by UV absorption 
spectrophotometer Jasco 7800 at λ=320 nm. The 
measurements were analyzed through a linear 
regression method, in which the correlation 
coefficient (R2= 0,999) and equation of a straight 
line were calculated. The percentage released at 
each point in time was expressed as a fraction of 
the total amount of Indo. Drug release was 
monitored for 8 hours; Indo concentration was 
reported as an average of three determinations and 
the error expressed as standard deviation (S.D.). 
 
RESULTS AND DISCUSSION  
 
X-ray powder diffraction (XRD): The “c” lattice 
parameter values for the studied samples have been 
included in Table 1. This parameter is calculated 
from the position of the first peak, plane 003 
(hexagonal packing is assumed) and c = 3d003. The 
interlayer distance value of d003, represents the 
summation of thickness of the brucite-like layer 
and the gallery height, which is a function of the 
number, the size and the orientation of intercalated 
anions. For the hydrotalcite interlayer with 
chlorides, the d-spacing for planes (003) with a 
hexagonal packing is in the range of 7.66 Å, which 
represents a value of 11.54 at 2θ. Since the brucite-
like layer thickness of LDH is 4.8 Å [1], the 
interlayer space is 2.86 Å (Fig. 1A).  
 
Successful intercalation of Indo into the LDH host 
is demonstrated by the XRD diagrams of the 
nanohybrids. During the coprecipitation, the layers 
of LDH expand to host the pharmaceutical anions 
and this expansion is reflected by the values of d003 
which are also given in Figure 1B, such a swelling 
of the layers being due to the intercalation of the 
drug molecules.  
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The interlayer distance increased from 2.86 to 
18.00 Å (22.8-4.8 Å) for the sample synthetized at 
pH 8 and from 2.86 to 19.25 Å (d=24.05 Å) for the 
samples synthetized at pH 9 and 10. 
 
In samples synthesized at pH 9 and 8 (Fig.1B b-c), 
peaks corresponding to the pure drug were 
observed which would indicate that it is adsorbed 
on the solid surface. The observed peaks indicate 
that γ-Indomethacin suffers a transformation due to 
the thermal treatment performed during synthesis 
and the observed peaks corresponding to α-
Indomethacin polymorph [30, 37].  At pH 9, both 
structures can be seen, LDH-Indo as well as the 
peaks belonging to absorbed drug α-Indomethacin. 
In contrast, in the synthesis performed at pH 8, the 
incorporated drug can be observed in the plane 003 
in a disordered manner. This is due to that at low 
values of 2θ, it has different peaks, indicating that 
the position in the interlayer is not arranged, as at 
higher pH. The peaks are less intense and wider, 
indicating a more disordered disposition after 
intercalation [16]. At pH 10, they show a higher 
order crystalline LDH structure (Fig.1B a). Given 
that, the incorporation is partial; there are two types 
of the interlayer sizes, corresponding to the LDH-
Indo and the LDH-Cl host. The peak at 11.35 at 2θ 
(marked by ■) in Figure 1B(a), corresponds to the 
planes (003) reflection of LDH-Cl, overlapped whit 
the (009) reflection of LDH–Indo; that was 
observed at pH 9 and 10 [38, 39].  
 
The symmetric reflections (110) and (113) merged 
in the sample synthesized at pH 10, indicating a 
disturbance of the brucite-like layer structure. 
These reflections were not observed in the samples 
synthesized at pH 8 and 9 which would reveal the 
presence of brucite-like layers in thin films [16, 39-
40].  
 
Fourier Transform Infrared Spectroscopy 
(FTIR): Figure 2 shows FTIR spectra for α-
Indomethacin and γ-Indomethacin, which have 
different absorption bands in the carbonyl region. 
As Chen et al. [41] proposed, the γ-Indomethacin 
has characteristic absorption bands at 1717 and 
1692 cm-1. The 1717 cm-1 absorption band is 
assigned to the carbonyl stretch of the acid dimmer. 
The 1692 cm-1 absorption band is assumed to be the 
carbonyl stretch of non-protonated amide. The α-
Indomethacin has characteristic absorption bands at 
1735, 1692, 1680 cm-1, which is related to its 
crystal structure. The 1735 cm-1 adsorption band is 
assigned to the non-dimer involved carboxylic acid 
carbonyl, while the adsorption band for the 
carboxylic acid dimer is presumed to be the 
unresolved shoulder near 1717 cm-1. The 1692 cm-1 
adsorption band in both forms is assumed to be the 
carbonyl stretch of non-protonated amide, while the 
adsorption band at 1680 cm−1 is assigned to the 
protonated amide. 
 
The FT-IR spectra of LDH-Cl and intercalated 
LDH-Indo materials synthesized at different pH 
values are shown in Figure 3. In Figure 3 (b to d), a 
decrease in the characteristic bands of the pure drug 
is observed, when the pH increases from 8 to 10. 
At pH 10, the pure drug bands are less intense; this 
reveals a lower incorporation, which corresponds to 
the diffraction pattern obtained. The band at 1560 
cm-1 corresponds to the carboxylate group, so it can 
be inferred that the drug is in its anionic species 
and incorporated into the LDH. The band at 1680 
cm-1, indicates that the γ-Indomethacin suffers a 
transformation during the incorporation to α-
Indomethacin.  
 
Scanning Electron Microscopy (SEM): As shown 
in Figure 4, the SEM of the LDH-Indo materials 
synthesized at different pH values is different. The 
LDH-Indo synthesized at pH 8 (Fig. 4-a) shows a 
structure of threads, this morphology is 
characteristic of the α-Indomethacin polymorph 
[30, 42]. The presence of this structure confirms 
the findings of DRX. When the pH of synthesis is 
increased, the wire structure disappears and the 
characteristic, layered structure of the LDH is 
observed. In the samples synthesized at pH 9, 
amorphous grains of different size and smaller 
needles were observed (Fig. 4 (b)). In the LDH-
Indo synthesized at pH 10, similarly sized, uniform 
particles (Fig. 4c) were observed. In this case, 
sheets are well-formed, resulting in the aggregate 
which takes the form of rosettes. Figure 4 (d) 
shows an enlarged area of LDH to pH 10 (marked 
area), which displays, with more detail, the 
structure similar to a rosette. This structure is 
favored by the heat treatment, aging temperature 
and pH synthesis mainly, which coincides with the 
observations made by Faour et al. [43, 44].  
 
Transmission Electron Microscopy (TEM): TEM 
of LDH-Indo were illustrated in Figure 5. The 
differences observed are mainly due to the ordering 
of the lamellar structure. In the sample synthesized 
at pH 8 (Fig. 5 (a)), individual, thin and disordered 
sheets are observed, while in the sample 
synthesized at pH 10 (Fig. 5(b)), a high order of the 
layer is noticed (demarcated area). This structure 
corresponds to that observed by XRD. 
 
Drug Loading: Table 1 shows the percentage of 
incorporation for each LHD synthesized. It can be 
observed that the incorporation of the drug 
decreases with increasing pH of synthesis. This 
behavior may be due to the increase in the 
crystalline structure of solids, as it was previously 
discussed. The materials synthesized at lower pH 
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(8 and 9) showed a more disordered layer structure 
which favors the incorporation of the drug, either in 
the interlayer  or being adsorbed on the external 
surface.  More importantly, the LDH-Cl showed no 
absorption at 320 nm. 
 
Thermal Analysis: Thermal behaviour was 
determinate by TG and DSC, the curves of LDH-Cl 
and LDH-Indo synthesized at different pH values, 
are illustrated in Figures 6 and 7. For LDH-Cl, the 
host solid, (Fig. 6-a) three weight loss stages can be 
observed. The first stage, whose weight loss is 
below 160 °C, was produced due to physically 
adsorbed water. The second stage corresponds to 
the loss of interlayer water (180 – 250 °C). Finally, 
the third stage (250 – 600 ºC) is attributed to the 
dehydroxylation of the brucite-like sheets and the 
loss of interlayer ions in the form of HCl and Cl2 
indicating that the layer has disappeared.  
 
The TG curves of LDH-Indo synthesized at pH 8 
and 9 are illustrated in Figure 6 (b) and (c), the 
total weight loss (Table 2) for both solids was 
similar (about 85%).  These values, in both cases, 
are higher than the obtained at pH 10 (66,70%), 
Figure 6 (c). This behavior is related to the capacity 
to incorporate each of them. The first stage, from 
room temperature (RT) to 230 ºC, exhibits that the 
weight loss in the three samples is about 12%; 
however, at temperatures above 230 °C, the 
samples synthesized at pH 8 and 9 show a higher 
weight loss than the sample synthesized at pH 10. 
This indicates the greatest interaction of the drug 
with the brucite layer and the increase in the 
formation of the lamellar structure, as was 
observed by DRX.  
 
The DSC curves for LDH-Cl and the LDH-Indo 
synthesized at pH 8, 9 and 10 are shown for 
comparison in Figure 7. Indo displayed an 
endothermic peak at 161.26 °C which corresponds 
to its melting point [29, 36]. The samples with 
incorporated Indo showed an endothermic peak at 
112 ºC due to loss of surface adsorbed and 
interlayer water. The first exothermic peak 
corresponding to the possible decomposition of 
Indo is approximately 270 °C in the samples 
synthesized at pH 9 and 10 (curve (c) and (d)); at 
the same temperature, in the LDH-Indo synthesized 
at pH 8, an endothermic peak was observed. This 
indicates that there is little interaction between the 
drug and the brucite layer as well as there is also 
drug on the surface, this result is consistent with 
what is observed by XRD. It can be inferred that 
the LDH host provides thermal stability to Indo up 
to 270°C, since the decomposition temperature of 
the pure drug is 161.26 °C. The last exothermic 
zone (350-650°C) could correspond to the removal 
of the interlayer drug and the dehydroxylation. The 
decomposition process occurs in multi-steps [16, 
17, 35, 45-46], forming CO2, NO2, and water 
vapor; unfortunately, the gases evolved during 
decomposition could not be analyzed. The stronger 
exothermic effects due to combustion probably 
masked the expected endothermic peaks between 
300 and 500 °C, due to dehydroxylation of the 
LDH, finally the complete decomposition occurred 
at 550 °C [8].  
 
UV-visible diffuse-reflectance spectroscopy (UV-
vis-DR): Photochemical tests : Figure 8 shows the 
UV-vis RD of LDH-Indo synthesized at different 
pH, without irradiation and with irradiation at 
different times (0.5, 7, 16 and 73 h). The host LDH 
did not present any remarkable absorption, as 
showed in Figure 8 I-(g). The samples synthesized 
at pH 9 and 10 did not present any significant 
changes until 16 hours of irradiation, which may 
suggest a stabilization of the drug in front of the 
light provided by the LDH host [13]. However, the 
sample synthesized at pH 8 showed a shoulder 
around 450 nm (marked zone), suggesting a 
possible degradation of products. Since these 
products have not been identified, this area is still 
under study. It should be noted that, by XRD, 
laminar formation and a higher interaction with the 
interlayer at high pH was observed, whereas in the 
sample at pH 8, a greater adsorption of the drug on 
the surface was observed. In Figure 8, the (e) curve 
represents the UV-vis RD spectra for each pH, 
while (f) signals pure Indo irradiated for 73 h. At 
360 nm, the pure drug exhibits a shoulder (☼), 
which can be caused by the decomposition after 
irradiation time. This variation is not observed in 
the LDH-Indo at any synthesis pH.  This would 
indicate that Indo into LDH exhibited higher 
photostability to UV light irradiation since after 73 
hours of irradiation the drug is not significantly 
affected.  
 
Drug release: In vitro drug releases were 
performed in a phosphate buffer at pH 7.4±0.1, in 
order to mimic the small intestine environment. 
The profiles, at different pH are reported in Figure 
9. The profile was characterized by 8 hours. The 
sample synthesized at pH 8 exhibited the highest 
drug release, with 97%. At pH 9 and 10, the release 
was 92% and 67% respectively.  In the initial 15 
minutes, at pH 8 and 9, the drug release was 
similiar (17-14%) and at pH 10, the release was 
slower with 5%. At lower pH, the initial burst 
probably arose from the release of the drug 
absorbed on LDH matrix surface. 
 
The kinetic drug release was characterized by 
fitting standard release equations to experimental 
data. First order, Higuchi’s, Bhaskar’s, Ritger-
Peppas’s, and Kressman and Kitchener’s equations 
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were applied [17, 47-48] and the relative 
correlation coefficients are reported in Table 3. The 
Bhaskar equation fitting produces the highest R2 
values for drug diffusion through LDH which is 
strictly controlled by matrix. L. Pieroli et al. [48] 
proposed that LDH is a particular matrix; it could 
be able to control guest release by two processes: 
1) chemical, due to the selectivity towards different 
anions and ion-exchange mechanism, or 2) 
physical, due to the length of the obliged ways of 
galleries. In this case, the first process plays the key 
role for all release time.  
 
The cause of slow release at pH 10 may be 
attributed to the fact that the drug diffusion out of 
the LDH matrix is controlled by the rigidity of the 
structure layers, diffusion path length and the 
stronger electrostatic interaction between the Indo 
anions and LDH host layer [49]. However, at pH 8, 
the film type structure (observed by XRD) provides 
Indo with an easy access to the surface so a quick 
release in the first two hours is achieved and then, a 
controlled release is observed. Subsequently, at pH 
9, the release was much lower and sustained 
compared to pH 8. By comparing the Higuchi 
model, which presented low values of correlation, 
to the Bhaskar, it can be concluded that the release 
process is not due to the concentration of the drug. 
 
CONCLUSIONS 
 
Indo has been successfully incorporated into LDH 
at different pH of synthesis. The materials 
synthesized at lower pH (8 and 9) show a more 
disordered layer structure which favors the 
incorporation of the drug, either in the interlayer or 
by being adsorbed on the surface. At pH 10, the 
highest order of structure and the lowest 
incorporation can be observed.  
 
Indo suffers a morphological change due to the 
thermal treatment used. By DRX and SEM, it has 
been observed a progressive drug incorporation 
into the LDH layers with increasing pH. At lower 
pH, the formation of needles is observed (Indo own 
structure) which disappeared with increasing pH. 
The LDH provides thermal stability, with an 
increase in the thermal decomposition of the drug, 
around 100°C more. When Indo is intercalated into 
the LDH exhibited higher photostability to UV 
light irradiation since after 73 hours of irradiation 
the drug is not significantly affected. The LDH-
Indo synthesized at different pH provides a good 
support for controlled release. The ability to 
incorporate and release behavior can be controlled 
by the coprecipitation pH. The release profiles were 
fitted by mathematical models, being the Bhaskar 
kinetics model the most appropriate. It can be 
concluded that the release process is not due to the 
concentration of the drug. The host-guest 
interactions play an important role in the drug 
stability and release performance. 
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Table 1: pH of synthesis, interlayer distance and drug loading.  
 
 
 
 
 
 
 
 
 
 
Table 2: Weight lost mass of LDH-Indo synthesized. 
 
LDH-Indo 
pH synthesized 
Weight lost [%] Total Weight lost [%] 
RT-230 °C 230-400 °C 400-600 °C RT -600 °C 
8 11.56 33.98 40.99 86.53 
9 11.94 22.45 50.82 85.21 
10 11.24 18.86 36.60 66.70 
 
LDH synthesized pH of synthesis d (Å) 
Drug Loading 
[%] ± S.D 
LDH - Cl 10 7.66 ---- 
LDH-Indo 
8 22.80 66 ± 2 
9 24.05 60 ± 3 
10 24.05 56 ± 4 
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Table 3: Mathematical model fitting of release data. 
 
LDH-Indo 
pH synthesized 
Model kinetics - R2 
Higuchi Ritger-Peppas   n= 0.7            n=1 Bhaskar 1
st Order Kressman and Kitchener 
8 0.9292 0.8365 0.7327 0.9821 0.9432 0.9488 
9 0.9581 0.9056 0.8191 0.9960 0.9763 0.9763 
10 0.9873 0.9797 0.9161 0.9975 0.3966 0.9739 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 A: DRX of LDH-Cl. B: DRX LDH-Indo, (a) pH=10, (b) pH=9, (c) pH=8. 
 
 
 
 
 
 
 
 
 
Figure 2: FT-IR of (a) γ-Indomethacin and (b) α-Indomethacin. 
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Figure 3: FT -IR of (a) LDH-Cl and LDH-Indo, (b) pH=8, (c) pH=9, (d) pH=10. 
 
 
Figure 4: SEM of LDH-Indo. (a) pH=8, (b) pH=9, (c) pH=10 , (d) magnified image of pH=10. 
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Figure 5: TEM of LDH-Indo. (a) pH=8, (b) pH=10. 
 
 
 
 
 
 
 
 
 
 
Figure 6: TG of (a) LDH-Cl and LDH-Indo, (b) pH=8, (c) pH=9, (d) pH=10. 
 
 
 
 
 
 
 
 
 
 
Figure 7: DSC of (a) LDH-Cl and LDH-Indo, (b) pH=10, (c) pH=9, (d) pH=8. 
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Figure 8: UV-vis-RD of LDH-Indo, (I) pH=8, (II) pH=9, (III) pH=10, (a) without irradiation, (b) 30 min of 
irradiation, (c) 7 h of irradiation, (d) 16 h of irradiation, (e)73 h of irradiation, (f) Indo 73 h of irradiation, (g) 
LDH. 
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Figure 9: Release behavior of Indo from HDL-Indo of buffer simulated 7.4: (a) pH=8, (b) pH=9, (c) pH=10. 
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